Insider trading

Period: 120 months Stock: AUPH Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

71 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

71 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

71 decisions over 120 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

71 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
71 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
71 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

71 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
10 Sep 2026
Robertson Stephen P. Chief Legal Officer
Sold at will
$190.43K 11,939 at 15.95
2.0%
Not planned
21 Aug 2026
Robertson Stephen P. Chief Legal Officer
Sold at will
$355.95K 20,975 at 16.97
3.4%
Not planned
1 Aug 2025
Keenan Greg Chief Medical Officer
Sold at will
$210.00K 20,000 at 10.50
13.0%
Not planned
7 Mar 2025
Keenan Greg Chief Medical Officer
Sold at will
$68.35K 8,305 at 8.23
5.1%
Not planned
4 Mar 2025
Greenleaf Peter Chief Executive Officer
Sold at will
$1.31M 164,947 at 7.92
8.4%
Not planned
4 Mar 2025
Donley Matthew Maxwell Chief Operating Officer
Sold at will
$467.21K 58,991 at 7.92
8.0%
Not planned
4 Mar 2025
Robertson Stephen P. EVP, General Counsel
Sold at will
$456.25K 57,607 at 7.92
10.2%
Not planned
4 Mar 2025
Miller Joseph M Chief Financial Officer
Sold at will
$444.74K 56,154 at 7.92
8.9%
Not planned
3 Mar 2025
Greenleaf Peter Chief Executive Officer
Sold at will
$1.56M 195,593 at 8.00
9.1%
Not planned
3 Mar 2025
Donley Matthew Maxwell Chief Operating Officer
Sold at will
$527.22K 65,902 at 8.00
8.2%
Not planned
3 Mar 2025
Robertson Stephen P. EVP, General Counsel
Sold at will
$518.98K 64,872 at 8.00
10.3%
Not planned
3 Mar 2025
Miller Joseph M Chief Financial Officer
Sold at will
$494.87K 61,859 at 8.00
8.9%
Not planned
3 Mar 2025
Keenan Greg Chief Medical Officer
Sold at will
$97.91K 12,239 at 8.00
7.0%
Not planned
11 Nov 2024
Smith Karen L. Director
Sold at will
$44.18K 5,241 at 8.43
29.3%
Not planned
11 Nov 2024
Sold at will
$38.42K 4,557 at 8.43
25.4%
Not planned
6 Aug 2024
Habig Scott Michael Chief Commercial Officer
Sold at will
$96.90K 18,249 at 5.31
3.8%
Not planned
21 May 2024
Sold at will
$32.32K 5,630 at 5.74
23.2%
Not planned
21 May 2024
Leversage Jill Director
Sold at will
$32.20K 5,610 at 5.74
30.3%
Not planned
21 May 2024
Billen Daniel Director
Sold at will
$30.15K 5,252 at 5.74
15.7%
Not planned
21 May 2024
Jayne David R.W. Director
Sold at will
$28.39K 4,946 at 5.74
10.0%
Not planned
21 May 2024
Sold at will
$2.98K 520 at 5.74
2.9%
Not planned
6 Mar 2024
Greenleaf Peter Chief Executive Officer
Sold at will
$711.09K 126,981 at 5.60
7.7%
Not planned
6 Mar 2024
Robertson Stephen P. EVP, General Counsel
Sold at will
$323.37K 57,745 at 5.60
11.5%
Not planned
6 Mar 2024
Donley Matthew Maxwell EVP, Ops & Strategy
Sold at will
$224.06K 40,665 at 5.51
6.5%
Not planned
6 Mar 2024
Miller Joseph M Chief Financial Officer
Sold at will
$194.94K 34,811 at 5.60
6.6%
Not planned
6 Mar 2024
Habig Scott Michael Chief Commercial Officer
Sold at will
$99.55K 17,777 at 5.60
3.6%
Not planned
27 Feb 2024
Knappertz Volker EVP, Research and Development
Sold at will
$30.07K 4,930 at 6.10
1.5%
Not planned
20 Feb 2024
Knappertz Volker EVP, Research and Development
Sold at will
$137.80K 25,146 at 5.48
7.2%
Not planned
20 Feb 2024
Habig Scott Michael Chief Commercial Officer
Sold at will
$86.95K 15,867 at 5.48
3.1%
Not planned
23 May 2023
Jayne David R.W. Director
Sold at will
$98.33K 8,733 at 11.26
15.0%
Not planned
23 May 2023
Sold at will
$54.25K 4,818 at 11.26
16.6%
Not planned
23 May 2023
Leversage Jill Director
Sold at will
$54.22K 4,815 at 11.26
20.6%
Not planned
23 May 2023
Billen Daniel Director
Sold at will
$52.36K 4,650 at 11.26
12.2%
Not planned
19 May 2023
Hagan Joseph P Director
Sold at will
$2.88K 272 at 10.58
2.2%
Not planned
2 Mar 2023
Greenleaf Peter Chief Executive Officer
Sold, plan not stated
$292.79K 32,750 at 8.94
3.2%
2 Mar 2023
Robertson Stephen P. EVP, General Counsel
Sold, plan not stated
$173.45K 19,402 at 8.94
6.0%
2 Mar 2023
Miller Joseph M Chief Financial Officer
Sold, plan not stated
$100.99K 11,296 at 8.94
3.3%
2 Mar 2022
Greenleaf Peter Chief Executive Officer
Sold, plan not stated
$108.91K 9,068 at 12.01
21.6%
2 Mar 2022
Huizinga Robert Bindert EVP of Research
Sold, plan not stated
$58.24K 4,849 at 12.01
6.5%
2 Mar 2022
Martin Michael Robert Chief Business Officer
Sold, plan not stated
$58.24K 4,849 at 12.01
7.5%
2 Mar 2022
Solomons Neil Chief Medical Officer
Sold, plan not stated
$58.20K 4,846 at 12.01
5.1%
2 Mar 2022
Colao Massimilano Chief Commercial Officer
Sold, plan not stated
$38.49K 3,205 at 12.01
19.2%
2 Mar 2022
Miller Joseph M Chief Financial Officer
Sold, plan not stated
$36.75K 3,060 at 12.01
31.6%
2 Mar 2022
Donley Matthew Maxwell Ex VP, Intern'l Operations
Sold, plan not stated
$36.65K 3,052 at 12.01
15.8%
3 Jan 2022
Hagan Joseph P Director
Sold, plan not stated 2×
$903.65K 40,000 at 22.59
92.0%
Sold half or more
11 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$2.89M 100,000 at 28.89
53.4%
Sold half or more
11 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 2×
$1.16M 40,000 at 29.01
41.7%
10 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated 2×
$3.11M 100,000 at 31.11
53.4%
Sold half or more
10 Nov 2021
Martin Michael Robert Chief Business Officer
Sold, plan not stated 2×
$1.87M 60,000 at 31.14
47.3%
9 Nov 2021
Solomons Neil Chief Medical Officer
Sold, plan not stated
$1.51M 50,000 at 30.17
36.4%
Showing 1–50 of 71. Page 1 of 2 Older →